跳至主要内容
临床试验/ACTRN12607000564459
ACTRN12607000564459已完成4 期

A randomised, assessor blind, comparative trial of MOOV Lotion, MOOV Shampoo and KP24 Medicated Foam in the treatment of head lice in children as measured by the elimination of head lice after 3 weekly treatments

Ego Pharmaceuticals Pty. Ltd.0 个研究点目标入组 252 人开始时间: 2007年11月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
252

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
5 Years 至 12 Years(—)
性别
All

入选标准

  • •Male or female primary school-aged children.
  • •Presence of live head lice (adults or nymphs) on the hair or scalp. The presence of live lice will be determined from a visual inspection of the hair and scalp, and dry-combing of the hair. Combing will stop immediately once live lice are detected. The presence of lice eggs alone is not a sufficient condition for inclusion in the trial.
  • •Available for the duration of the trial.
  • •Parent / Guardian have given written informed consent to their child’s participation in the trial.

排除标准

  • •History of allergies or adverse reactions to head lice products or the components of the specific products being tested.
  • •Treatment with any head lice product in the 4 weeks prior to participation in this trial.
  • •Treatment with any head lice product during the trial.
  • •Treatment with a head lice comb during the trial if the subject is found to be louse free at Day 21 for any of the three treatment arms.
  • •Presence of scalp disease(s).
  • •If the subject has a sibling in Grade 1-7, who lived at the same residence during the treatment period the sibling must be examined for lice and if infested, enrolled in this study or wet combed out on days 0, 7 and 14, relative to the subject.
  • •Subjects must have one fixed place of residence during the trial.

研究者

相似试验

尚未招募
不适用
A randomized, blinded, comparator-controlled trial investigating a 28-day course of Lyrica in participants with knee osteoarthritis who exhibit neuropathic pain, compared with a 28-day course of acetaminophen.Musculoskeletal - OsteoarthritisOsteoarthritis
ACTRN12613000840785Dr Robert Will90
已完成
不适用
Kindaped™ lotion for treatment of head liceHead louse infestationInfections and Infestations
ISRCTN28722846Thornton & Ross Ltd (UK)120
尚未招募
4 期
Comparative trial of two gels in mild to moderate acne
CTRI/2019/08/020563KPC Medical College and Hospital
进行中(未招募)
1 期
Occurrence of hypophosphataemia in patients with iron deficiency anemia caused by inflammatory bowel disease after treatment with iron isomaltoside or iron carboxymaltoseIron deficiency anemia in subject with inflammatory bowel diseaseMedDRA version: 20.0Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 20.0Level: LLTClassification code 10079322Term: Anaemia of chronic inflammationSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2017-002452-87-DKPharmacosmos A/S120
进行中(未招募)
1 期
A study comparing the incidence of low phosphate levels in the blood (hypophosphatemia) after treatment with iron isomaltoside (Monofer®) and ferric carboxymaltose (Ferinject®) in patients with iron deficiency anaemia (low red blood cell count due to low iron levels in the blood) caused by swelling in the gut (known as inflammatory bowel disease).Iron deficiency anaemia due to inflammatory bowel diseaseMedDRA version: 20.0Level: LLTClassification code 10002062Term: Anaemia iron deficiencySystem Organ Class: 100000004851
EUCTR2017-002452-87-GBPharmacosmos A/S120